BESORFIB

Serial Number 87293657
606

Registration Progress

Application Filed
Jan 9, 2017
Under Examination
Jun 13, 2017
Approved for Publication
Apr 18, 2017
Published for Opposition
Apr 18, 2017
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: BESORFIB
Previous Owner: Pfizer Inc.
Classes: 005

Trademark Image

BESORFIB

Basic Information

Serial Number
87293657
Filing Date
January 9, 2017
Published for Opposition
April 18, 2017
Abandonment Date
July 20, 2020
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 20, 2020
Classes
005

Rights Holder

Pfizer Inc.

03
Address
235 East 42nd Street
New York, NY 10017

Ownership History

Pfizer Inc.

Original Applicant
03
New York, NY

Pfizer Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Heather McDonald

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

31 events
Date Code Type Description Documents
Jul 20, 2020 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 20, 2020 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 7, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 6, 2019 EX5G S SOU EXTENSION 5 GRANTED Loading...
Dec 4, 2019 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 6, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 4, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 18, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 16, 2019 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 16, 2019 EXT4 S SOU EXTENSION 4 FILED Loading...
May 16, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 21, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 19, 2018 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 19, 2018 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 19, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 23, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 21, 2018 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 21, 2018 EXT2 S SOU EXTENSION 2 FILED Loading...
May 21, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 4, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 2, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 2, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 2, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 13, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 18, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 18, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 29, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 3, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 2, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 16, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 12, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification

International Classes
005